DESVENLAFAXINE MARKET

INTRODUCTIONDESVENLAFAXINE MARKET

Headache, nausea, vomiting, diarrhoea, constipation, dry mouth, increased perspiration, decreased appetite, tremor, nervousness, restlessness, exhaustion, or problems sleeping (insomnia).

Bipolar illness also includes depression. Antidepressant-using bipolar patients run the danger of "flipping" from depression to mania.

Mania is characterised by "high" or irritated mood, extremely high self-esteem, decreased need for sleep, pressure to keep talking, racing thoughts, ease of distraction, and a propensity to engage in activities that carry a high risk of negative outcomes (for example, excessive buying sprees).

The FDA has approved the antidepressant desvenlafaxine for the treatment of major depressive disorder in adults. Desvenlafaxine can be used off-label to treat hot flashes in healthy women who are contraindicated to oestrogen.

Serotonin and norepinephrine reuptake inhibitors, such as venlafaxine, have been demonstrated in the TORDIA research to be effective in treating major depressive disorder in adolescents with treatment-resistant depression, despite not being FDA-approved for use in this age group.

This exercise will emphasise the desvenlafaxine mechanism of action, adverse event profile, off-label usage, dose, pharmacodynamics, pharmacokinetics, monitoring, and relevant interactions during desvenlafaxine therapy that are important for interprofessional team members.

DESVENLAFAXINE MARKET SIZE AND FORECAST

The Global DESVENLAFAXINE market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

DESVENLAFAXINE MARKETNEW PRODUCT LAUNCH

Desvenlafaxine Extended-Release Tablets, 25 mg, were introduced by Lupin Limited following approval from the US Food and Drug Administration (FDA).

Pristiq Extended-Release Tablets, 25 mg of PF PRISM C.V. are generically comparable to Desvenlafaxine Extended-Release Tablets, 25 mg. A prescription drug called Pristiq is used to treat the signs and symptoms of major depressive disorder.

Pristiq may be taken either by alone or along with other drugs. Pristiq, meanwhile, is a member of the SNRI (antidepressant) medication class.

Depression is treated with desvenlafaxine. It is said to function by raising levels of serotonin and norepinephrine, two naturally occurring chemicals in the brain that support mental equilibrium.

Desvenlafaxine is additionally occasionally used to treat hot flashes in postmenopausal females. Your energy level, mood, and sense of wellbeing might all get better as a result. As a serotonin-norepinephrine reuptake inhibitor, desvenlafaxine is well-known (SNRI).

DESVENLAFAXINE MARKETCOMPANY PROFILE

• MAYO
• NAMI
• NIH
• APOLLO
• STATPEARLS

THISDESVENLAFAXINE MARKETREPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many desvenlafaxine are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global desvenlafaxine and key vendor selection criteria
3. Where is the desvenlafaxine manufactured? What is the average margin per unit?
4. Market share of Global desvenlafaxine market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global desvenlafaxine in-house
6. key predictions for next 5 years in Global desvenlafaxine market
7. Average B-2-B desvenlafaxine market price in all segments
8. Latest trends in desvenlafaxine market, by every market segment
9. The market size (both volume and value) of the desvenlafaxine market in 2024-2030 and every year in between?
10. Production breakup of desvenlafaxine market, by suppliers and their OEM relationship